title: In response to Gudin et al. - Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties.
authors.affiliation: Medical Services, Purdue Pharma L.P, Stamford, Connecticut, CT, USA.
authors.forename: Nancy T
authors.initials: NT
authors.lastname: Crudele
authors.affiliation: Department of Medicine, Georgetown University, Washington, DC, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Giordano
authors.affiliation: Clinical Research & Development, Purdue Pharma LP, Stamford, Connecticut, USA.
authors.forename: Ram P
authors.initials: RP
authors.lastname: Kapil
authors.affiliation: Medical Services, Purdue Pharma L.P, Stamford, Connecticut, CT, USA.
authors.forename: Amarita S
authors.initials: AS
authors.lastname: Randhawa
mesh_terms: D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D006801:Humans; D009293:Opioid-Related Disorders; D010098:Oxycodone
chemical_list: D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D010098:Oxycodone